Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 24
206
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Synthesis and biological evaluation of camptothecin substituted norcantharimide derivatives

, , , & ORCID Icon
Pages 5752-5756 | Received 23 Jun 2020, Accepted 21 Sep 2020, Published online: 20 Oct 2020
 

Abstract

In this paper, a series of novel derivatives of camptothecin substituted norcantharimide was designed by mimic strategy. These compounds were synthesized in moderate yields by directly coupling CPT with N-amino acid norcantharimides. Their cytotoxicity to four human tumour cell lines (HepG2, BGC-803, SW480 and PANC-1) and normal human cell lines L-O2 and HIEC was evaluated. The synthesized CPT substituted norcantharimide analogs (3g and 3f) showed better anti-hepatocarcinoma activity than CPT. Compounds 3d, 3e, 3g, 3h and 3i also showed strong inhibition activity against BGC803.

Acknowledgments

I am very grateful for the financial support from Key Project of Guizhou Provincial Administration of Traditional Chinese Medicine (QZYYZD-2019-05), Joint fund project of Science and Technology Foundation of Zunyi City (ZunyiKeHe HZ [2019]26), Guizhou Provincial Administration of Traditional Chinese Medicine (QZYY2017-030), Science and Technology Foundation of Guizhou Province (QianKeHe Platform/talent[2019]5657), Public Bidding Project Foundation of Zunyi Medical University ([2013]F-680), Doctoral Scientific Research Foundation of Zunyi Medical University ([2013]F-633) and [2014]F-697), Science and Technology Foundation of Guizhou Province (QianKeHe ZhiCheng [2019]2829), and I am also very thankful for Dr. Yuqi He’s useful explanation on MS spectrum data.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.